Golden-Horse Pharmaceutical Receives Regulatory Approval for New Alzheimer's Drug

Stock News06-25

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SHE: 000766) has announced that it has received the Drug Registration Certificate from the National Medical Products Administration for its Succinyl Anviatridine Tablets.

The drug, marketed under the brand name Mao An Tong, is a novel dual cholinesterase inhibitor. It works by reversibly inhibiting the hydrolysis of acetylcholine and butyrylcholine by acetylcholinesterase and butyrylcholinesterase. This mechanism increases the concentration of acetylcholine in the cholinergic nerve synaptic clefts of the brain, thereby enhancing cholinergic nerve function and improving cognitive function in patients with Alzheimer's disease.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156401798?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-25 15:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156401798","market":"hk","top_or_hot":-1,"title":"Golden-Horse Pharmaceutical Receives Regulatory Approval for New Alzheimer's Drug","media":"Stock News","content":"<p><b>Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.</b> (<b>SHE: 000766</b>) has announced that it has received the Drug Registration Certificate from the National Medical Products Administration for its Succinyl Anviatridine Tablets.<br><br>The drug, marketed under the brand name Mao An Tong, is a novel dual cholinesterase inhibitor. It works by reversibly inhibiting the hydrolysis of acetylcholine and butyrylcholine by acetylcholinesterase and butyrylcholinesterase. This mechanism increases the concentration of acetylcholine in the cholinergic nerve synaptic clefts of the brain, thereby enhancing cholinergic nerve function and improving cognitive function in patients with Alzheimer's disease.<br><br></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Golden-Horse Pharmaceutical Receives Regulatory Approval for New Alzheimer's Drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGolden-Horse Pharmaceutical Receives Regulatory Approval for New Alzheimer's Drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-25 15:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.</b> (<b>SHE: 000766</b>) has announced that it has received the Drug Registration Certificate from the National Medical Products Administration for its Succinyl Anviatridine Tablets.<br><br>The drug, marketed under the brand name Mao An Tong, is a novel dual cholinesterase inhibitor. It works by reversibly inhibiting the hydrolysis of acetylcholine and butyrylcholine by acetylcholinesterase and butyrylcholinesterase. This mechanism increases the concentration of acetylcholine in the cholinergic nerve synaptic clefts of the brain, thereby enhancing cholinergic nerve function and improving cognitive function in patients with Alzheimer's disease.<br><br></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0060","symbol_name":"抗癌","start_time":0,"source_url":"","article_id":"1156401798","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156401798","pubTimestamp":1782373719,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SHE: 000766) has announced that it has received the Drug Registration Certificate from the National Medical Products Administration for its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0060":"抗癌","BK0239":"医药制造","BK0077":"质押式回购","000766":"通化金马"},"translate_title":"金马药业阿尔茨海默病新药获得监管部门批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000766":1},"content_text":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SHE: 000766) has announced that it has received the Drug Registration Certificate from the National Medical Products Administration for its Succinyl Anviatridine Tablets.The drug, marketed under the brand name Mao An Tong, is a novel dual cholinesterase inhibitor. It works by reversibly inhibiting the hydrolysis of acetylcholine and butyrylcholine by acetylcholinesterase and butyrylcholinesterase. This mechanism increases the concentration of acetylcholine in the cholinergic nerve synaptic clefts of the brain, thereby enhancing cholinergic nerve function and improving cognitive function in patients with Alzheimer's disease.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156401798","isCrawlerRequest":true}